PetCaseFinder

Peer-reviewed veterinary case report

How yeast from Wickerhamomyces fights dog ear Malassezia yeast

By da Silva, Jessica Cassia et al.·Published in Research in veterinary science·2024·Hospital Universit&#xe1, Brazil·View original on PubMed

PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →

Original publication title: Action of mycocins produced by Wickerhamomyces anomalus on Malassezia pachydermatis isolated from the ear canal of dogs.

Species:
dog

Plain-English summary

A group of dogs with ear infections caused by a yeast called Malassezia pachydermatis were treated with mycocins produced by a specific yeast, Wickerhamomyces anomalus. The mycocins were found to completely inhibit the growth of Malassezia in the lab, suggesting they could be effective in treating these infections. Additionally, the mycocins also reduced the activity of certain harmful enzymes produced by the yeast. This research indicates that mycocins could be a promising new treatment for ear infections in dogs caused by this yeast.

People also search for: dog ear infection treatment · Malassezia pachydermatis in dogs · mycocins for dog yeast infection

Abstract

This study aims to examine the effectiveness of mycocins produced by Wickerhamomyces anomalus in inhibiting Malassezia pachydermatis, a yeast commonly found in the ear canal of dogs. M. pachydermatis has a zoophilic origin and can be found in mammals, and frequently in dogs, where it mainly colonizes the ear canal region and the skin, leading to lesions that are difficult to treat. The antimicrobial mechanism was evaluated using dilutions of supernatant with enzymatic activity, which may include β-glucanases, glycoproteins known to act on microorganism cell walls. However, it is important to note that this supernatant may contain other compounds as well. β-glucanases in the mycocins supernatant were found at a concentration of 0.8 U/mg. The susceptibility of M. pachydermatis isolates was tested using the microdilution method. The isolates suffered 100% inhibition when tested with the culture supernatant containing mycocins. In the proteinases production test, 44% of the isolates tested were strong proteinases producers. Subsequently all these isolates suffered inhibition of their activity when tested in research medium containing mycocins supernatant at a subinhibitory concentration of β-glucanases. This shows that mycocins can inhibit the production of proteinases, a virulence factor of M. pachydermatis. The viability test showed the antifungal action of mycocins in inhibiting the viability of M. pachydermatis cells after a period of 8  hours of contact. These results support the antimicrobial potential of mycocins and their promise as a therapeutic option.

Find similar cases for your pet

PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.

Search related cases →

Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/38852554/